Literature DB >> 35586424

3-Pyrrolidine-indole Derivatives as 5-HT2-Selective Receptor Modulators for the Potential Treatment of Mental Disorders.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2022        PMID： 35586424      PMCID： PMC9109475          DOI： 10.1021/acsmedchemlett.2c00128

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

1.  Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery.

Authors:  Samuel Obeng; Takato Hiranita; Francisco León; Lance R McMahon; Christopher R McCurdy
Journal:  J Med Chem       Date:  2021-05-06       Impact factor: 7.446

2.  Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.

Authors:  Danilo De Gregorio; Argel Aguilar-Valles; Katrin H Preller; Boris Dov Heifets; Meghan Hibicke; Jennifer Mitchell; Gabriella Gobbi
Journal:  J Neurosci       Date:  2020-11-30       Impact factor: 6.167

Review 3.  Psychedelic medicines for mood disorders: current evidence and clinical considerations.

Authors:  Jerome Sarris; Diego Pinzon Rubiano; Kimberley Day; Nicole L Galvão-Coelho; Daniel Perkins
Journal:  Curr Opin Psychiatry       Date:  2022-01-01       Impact factor: 4.741

Review 4.  Beating pain with psychedelics: Matter over mind?

Authors:  Igor Elman; Amanda Pustilnik; David Borsook
Journal:  Neurosci Biobehav Rev       Date:  2021-12-16       Impact factor: 8.989

Review 5.  Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.

Authors:  Nina Schimmel; Joost J Breeksema; Sanne Y Smith-Apeldoorn; Jolien Veraart; Wim van den Brink; Robert A Schoevers
Journal:  Psychopharmacology (Berl)       Date:  2021-11-23       Impact factor: 4.530

Review 6.  Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity.

Authors:  David E Olson
Journal:  Biochemistry       Date:  2022-01-21       Impact factor: 3.162
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.